Literature DB >> 15149796

Avian adenovirus CELO recombinants expressing VP2 of infectious bursal disease virus induce protection against bursal disease in chickens.

Achille Francois1, Christophe Chevalier, Bernard Delmas, Nicolas Eterradossi, Didier Toquin, Gaëlle Rivallan, Patrick Langlois.   

Abstract

To develop a CELO virus vector that can induce protection against infectious bursal disease, CELO viruses expressing the host-protective antigen VP2 of infectious bursal disease virus (IBDV) were constructed. In the engineered recombinants, the VP2 gene (the 441-first codons of the IBDA polyprotein) was placed under the control of the CMV promoter. Two positions in the CELO genome were chosen to insert the VP2 expression cassette. The recombinants were found apathogenic, when inoculated by different routes and even at high doses (up to 10(8) per animal). Chickens vaccinated oro-nasally with these different recombinants and challenged with very virulent IBDV were found to be poorly protected. In contrast, when inoculated with one or two (subcutaneous or intradermic) injections of CELOa-VP2, the chickens showed no clinical signs and no mortality after challenge. In the vaccinated chickens, the titers of neutralization antibody reached 7-9 values, showing that protection could be explained by the induction of a sufficient humoral response. After challenge, the weight ratio Bursa of Fabricius/body was about 2.5 per thousand, a value similar to that obtained with the commercial Bur706 vaccine. However, histological lesions in the Bursa of Fabricius were observed, showing that a complete protection was not totally achieved. Contact transmission was evidenced. Protection was also obtained when inoculation of CELOa-VP2 was carried out in ovo. Prime-boost strategies were also tested with the CELOa-VP2 vector used in association with the purified VP2 antigen, or DNA encoding VP2 or a CELO vector expressing chicken myeloid growth factor (cMGF). None of these regimens were shown to substantially increase the level of protection when compared to double CELOa-VP2 inoculations. These results indicate that CELO-based vectors are useful to safely induce a strong protective immunity against vvIBDV in chickens.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15149796     DOI: 10.1016/j.vaccine.2003.10.039

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  23 in total

1.  Identification of HI-like loop in CELO adenovirus fiber for incorporation of receptor binding motifs.

Authors:  Denis Y Logunov; Olga V Zubkova; Anna S Karyagina-Zhulina; Eugenia A Shuvalova; Andrei P Karpov; Maxim M Shmarov; Irina L Tutykhina; Yulia S Alyapkina; Natalia M Grezina; Natalia A Zinovieva; Lev K Ernst; Alexsandr L Gintsburg; Boris S Naroditsky
Journal:  J Virol       Date:  2007-06-27       Impact factor: 5.103

2.  Crystallization of the C-terminal head domain of the avian adenovirus CELO long fibre.

Authors:  Pablo Guardado Calvo; Antonio L Llamas-Saiz; Patrick Langlois; Mark J van Raaij
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2006-04-12

Review 3.  Economically important non-oncogenic immunosuppressive viral diseases of chicken--current status.

Authors:  V Balamurugan; J M Kataria
Journal:  Vet Res Commun       Date:  2006-07       Impact factor: 2.459

4.  Structural basis for the development of avian virus capsids that display influenza virus proteins and induce protective immunity.

Authors:  Elena Pascual; Carlos P Mata; Josué Gómez-Blanco; Noelia Moreno; Juan Bárcena; Esther Blanco; Ariel Rodríguez-Frandsen; Amelia Nieto; José L Carrascosa; José R Castón
Journal:  J Virol       Date:  2014-12-17       Impact factor: 5.103

5.  Oral inoculation of chickens with a candidate fowl adenovirus 9 vector.

Authors:  Li Deng; Shayan Sharif; Eva Nagy
Journal:  Clin Vaccine Immunol       Date:  2013-06-05

6.  First step in characterization of cis-acting sequences involved in fowl adenovirus 1 (CELO) packaging and its effect on the development of a helper-dependent vector strategy.

Authors:  Claire Barra; Patrick Langlois
Journal:  Virus Genes       Date:  2008-09-30       Impact factor: 2.332

7.  Protective vaccination against infectious bursal disease virus with whole recombinant Kluyveromyces lactis yeast expressing the viral VP2 subunit.

Authors:  Marina Arnold; Vijay Durairaj; Egbert Mundt; Katja Schulze; Karin D Breunig; Sven-Erik Behrens
Journal:  PLoS One       Date:  2012-09-14       Impact factor: 3.240

8.  An update on canine adenovirus type 2 and its vectors.

Authors:  Thierry Bru; Sara Salinas; Eric J Kremer
Journal:  Viruses       Date:  2010-09-27       Impact factor: 5.818

9.  Protection of chicken against very virulent IBDV provided by in ovo priming with DNA vaccine and boosting with killed vaccine and the adjuvant effects of plasmid-encoded chicken interleukin-2 and interferon-gamma.

Authors:  Jeong Ho Park; Haan Woo Sung; Byung Il Yoon; Hyuk Moo Kwon
Journal:  J Vet Sci       Date:  2009-06       Impact factor: 1.672

10.  A Single Amino Acid at Residue 188 of the Hexon Protein Is Responsible for the Pathogenicity of the Emerging Novel Virus Fowl Adenovirus 4.

Authors:  Yu Zhang; Aijing Liu; Yanan Wang; Hongyu Cui; Yulong Gao; Xiaole Qi; Changjun Liu; Yanping Zhang; Kai Li; Li Gao; Qing Pan; Xiaomei Wang
Journal:  J Virol       Date:  2021-08-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.